• About
  • Subscribe
  • Advertise
  • Contact
Friday, March 13, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

COVID-19: Implications for ECPs amid airborne transmission debate

by Myles Hume
July 21, 2020
in Local, News
Reading Time: 5 mins read
A A
The ability of SARS-CoV-2 to induce serious ocular disease has remained largely unknown.

The ability of SARS-CoV-2 to induce serious ocular disease has remained largely unknown.

Share on FacebookShare on Twitter

Australian optometrists are being advised to consider improving airflow and ventilation within their practices after the World Health Organization acknowledged it could not rule out the possibility of airborne transmission of COVID-19 in indoor settings.

With the true extent of asymptomatic infection not yet known, the WHO’s updated position has potential implications for eyecare professionals and came just days before a Medical Journal of Australia article outlined the evidence for airborne transmission. It estimated there have been 500 health worker infections in Australia, despite there being no national reporting system.

In response to these developments, Optometry Australia said optometrists should consider ventilation, including opening windows – or at least the consulting room door – where practical to improve airflow. This is in addition to previous advice that all optometrists in Greater Melbourne and Mitchell Shire seeing any patient for any reason should wear a standard surgical mask.

The organisation also points to Australian Department of Health Coronavirus Disease (COVID-19) Social distancing guidelines that suggest considering “opening windows and adjusting air conditioning for more ventilation”.

“Obviously in most optometry outpatient settings there is limited control over ventilation, and ventilation standards are not the same as controlled hospital settings,” OA noted, with more information available here.

Airborne transmission possible

In its most definitive statement on COVID-19 spread published on 9 July, the WHO said airborne transmission was possible in some indoor settings such as crowded and inadequately ventilated spaces over a prolonged period of time.

Airborne transmission is caused by the dissemination of droplet nuclei (aerosols) measuring <5μm that remain infectious when suspended in air over long distances and a long period of time.

Until now, the WHO said that airborne transmission of the virus only occurred in healthcare settings during aerosol generating procedures. (RANZCO states that phacoemulsification, vitrectomy, laser refractive surgery and oculoplastic surgery where cautery or high-speed instruments are used, may be aerosol generating procedures).

It has maintained that the primary form of coronavirus transmission is via respiratory droplets passed through close contact with people who are infected. It is also likely that people can become infected touching contaminated surfaces.

Optometry practice staff in Melbourne are being advised to wear masks for all patients.

While it could not rule out airborne transmission in poorly ventilated indoor locations such as choir practice, restaurants or fitness classes, it stressed investigations of these clusters suggest that droplet and fomite (contaminated surfaces) transmission could also explain the spread in these circumstances.

The WHO noted that some studies conducted in healthcare settings where symptomatic COVID-19 patients were cared for, but where aerosol generating procedures were not performed, reported the presence of SARS-CoV-2 RNA in air samples. However, other similar investigations in both healthcare and non-healthcare settings did not reach the same finding.

“Further studies are needed to determine whether it is possible to detect viable SARS-CoV-2 in air samples from settings where no procedures that generate aerosols are performed and what role aerosols might play in transmission,” the WHO noted.

Strength of evidence questioned

In an article published in the Medical Journal of Australia on 14 July, lead author Professor Raina MacIntyre, an infectious diseases expert from the University of New South Wales, said the initial proclamation that SARS-CoV-2 is spread by droplets and contact was not based on strong evidence, and there is no data quantifying the different modes of potential transmission.

“The guidelines for protection of healthcare workers in Australia state that a medical mask is indicated for routine care of COVID-19 patients, and a respirator only for aerosol-generating procedures. These guidelines are not aligned with the growing body of scientific evidence around transmission and prevention of SARS-CoV-2 infection,” the article said.

In their work that outlines the evidence of airborne transmission, MacIntyre and her colleagues note there were more than 500 health worker infections in Australia by July, but no national reporting on health worker infections, and lack of transparency in attribution of the source of infection.

When caring for someone with confirmed or suspected COVID-19, the Department of Health advises using a surgical mask. A P2/N95 respirator (pictured) should be used instead if there is frequent close contact the patient or for procedures that generate aerosols.

Importantly, they say that guidelines on ‘droplet precautions’ (masks) and ‘airborne precautions’ (respirators) assume that respiratory emissions can be separated into mutually exclusive groups – droplet and airborne spread.

But this assumption is based on limited data from the 1930s, with newer studies showing that droplets and aerosol particles exist in a continuum; a single large droplet may reduce in diameter and become airborne during its trajectory, because of evaporation.

“We suggest that all health workers treating COVID-19 patients be provided airborne precautions, that … the precautionary principle be applied to health worker protection. We also require transparent national reporting of health worker infections. This is particularly urgent as numerous health worker infections have been reported in hospitals in Victoria during Australia’s resurgence of COVID-19.”

Exception rather than the rule  

In an article written for The Journal of the American Medical Association on 13 July, Dr Michael Klompas and his colleagues from the Harvard Medical School said demonstrating that speaking and coughing can generate aerosols or that it is possible to recover viral RNA from air does not prove aerosol-based transmission.

“Proponents of aerosol-based transmission cite well-documented clusters of infections among choir participants, restaurant patrons, and office workers sharing closed indoor spaces. However, based on the reproduction number for SARS-CoV-2, these events appear to be the exception rather than the rule,” they said.

“It is impossible to conclude that aerosol-based transmission never occurs and it is perfectly understandable that many prefer to err on the side of caution, particularly in healthcare settings when caring for patients with suspected or confirmed COVID-19. However, the balance of currently available evidence suggests that long-range aerosol-based transmission is not the dominant mode of SARS-CoV-2 transmission.”

Tags: airborne transmissionCOVID-19dropletfomiteOAOptometry AustraliaProfessor Raina MacIntyreUniversity of New South WalesventilationWorld Health Organizatio

Related Posts

Bausch + Lomb’s new enVista Aspire intermediate-optimised IOL. Image: B+L.

Intermediate-optimised IOL bringing patient success

by Rob Mitchell
March 13, 2026

An ophthalmologist in New Zealand was the first in the Southern Hemisphere to try Bausch + Lomb’s new enVista Aspire...

Dr Michele Ginocchietti. Image: EssilorLuxottica

Global executive appointed to lead EssilorLuxottica in ANZ

by Staff Writer
March 12, 2026

Dr Michele Ginocchietti has been appointed head of ANZ at EssilorLuxottica, bringing more than a decade of experience within the...

55.2% of children wearing Abiliti 1-Day showed no clinically meaningful myopia progression* over three years.^1. Image: J &J Vision.

Putting compliance first – new data for ACUVUE Abiliti 1‑Day reinforces efficacy, wearability

by Staff Writer
March 12, 2026

Johnson & Johnson Vision (J&J Vision) says the myopia conversation in optometry practice has shifted from “if” to “when” and...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited